VALION BIO INC
VBIONASDAQTrading Snapshot
- Day Range
- $393.02 – $399.40
- 52-Week Range
- $0.25 – $1.21
- Volume
- $2.73B
- Avg Volume
- $2.43B
- Shares Outstanding
- 4.2M
- Next Earnings
- Sep 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $477,641
- Last Q Revenue
- $120,340
- P/E Ratio
- —
- P/S Ratio
- 2.4x
- EPS (TTM)
- $-8.23
- Dividend Yield
- —
Why Investors Own VBIO
- ✓High-growth profile — revenue up +27.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 29% gross margin and 20% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About VALION BIO INC
A company profile for VALION BIO INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Price Target
ⓘLatest News & Updates
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million. BGM Group (NASDAQ:BGM) stock rose 11.63%
Ukraine's Ministry Of Health Accepts Valion Bio's Regulatory Dossier For Entolimod For Formal Review Under Regulatory Equivalence Pathway
Valion Bio, Inc. (NASDAQ:VBIO) today announced that Ukraine's Ministry of Health (MoH) has accepted the Company's regulatory dossier for Entolimod—a medical countermeasure for Acute Radiation Syndrome (ARS)—for
Tuesday's after hours session: top gainers and losers
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Which stocks are moving on Monday?
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Valion Bio To Carry Out Study At Sheba Medical Center To Mull Entolimod In 10 Cancer Participants
Valion Bio, Inc. (NASDAQ:VBIO) today announced a major clinical development milestone with the finalization of an clinical trial protocol at Sheba Medical Center, one of the world's leading hospitals, to evaluate
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million. Advanced Biomed (NASDAQ:ADVB) stock moved